CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
BMC Cancer Sep 11, 2017
Hallamies S, et al. Â The aim of this study was to determine whether CHEK2 c.1100delC mutation is associated with an increased risk of male breast cancer (MBC) in Finnish patient population. On the basis of the data collected, it was concluded that the CHEK2 c.1100delC mutation was related to an increased risk for MBC in the Finnish population.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
